Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Jacob Schuringa

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
Blood|November 20, 2010
Tracing C/EBPα+ cells and their progenyJan Jacob Schuringa
Blood|March 11, 2017
Smart niche usage: release its fat and burn it!Jan Jacob Schuringa
Cancer Cell|December 15, 2020
Dissecting Clonal Heterogeneity in AMLJan Jacob Schuringa, Constanze Bonifer
Methods in Molecular Biology (Clifton, N.J.)|March 12, 2009
Ex vivo assays to study self-renewal and long-term expansion of genetically modified primary human acute myeloid leukemia stem cellsJan Jacob Schuringa, Hein Schepers
Blood|February 19, 2026
Glutathionylated leaky mitochondrial pores as target in AMLDiego Pereira-Martins, Jan Jacob Schuringa
Biochemical Pharmacology|April 17, 2010
Apoptosis and cancer stem cells: Implications for apoptosis targeted therapyFrank A E Kruyt, Jan Jacob Schuringa
Blood|December 24, 2024
Menin inhibitors in the treatment of acute myeloid leukemiaGerwin Huls, Carolien M Woolthuis, Jan Jacob Schuringa
Plos One|November 1, 2014
ELMO1 is upregulated in AML CD34+ stem/progenitor cells, mediates chemotaxis and predicts poor prognosis in normal karyotype AMLMarta E Capala, Edo Vellenga, Jan Jacob Schuringa
STAR Protocols|October 8, 2021
CombiFlow: Flow cytometry-based identification and characterization of genetically and functionally distinct AML subclonesRoos Houtsma, Shanna M Hogeling, Jan Jacob Schuringa
Plos One|April 2, 2014
Convergence of hypoxia and TGFβ pathways on cell cycle regulation in human hematopoietic stem/progenitor cellsAlbertus T J Wierenga, Edo Vellenga, Jan Jacob Schuringa
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
Blood|November 20, 2010
Tracing C/EBPα+ cells and their progenyJan Jacob Schuringa
Blood|March 11, 2017
Smart niche usage: release its fat and burn it!Jan Jacob Schuringa
Cancer Cell|December 15, 2020
Dissecting Clonal Heterogeneity in AMLJan Jacob Schuringa, Constanze Bonifer
Methods in Molecular Biology (Clifton, N.J.)|March 12, 2009
Ex vivo assays to study self-renewal and long-term expansion of genetically modified primary human acute myeloid leukemia stem cellsJan Jacob Schuringa, Hein Schepers
Blood|February 19, 2026
Glutathionylated leaky mitochondrial pores as target in AMLDiego Pereira-Martins, Jan Jacob Schuringa
Biochemical Pharmacology|April 17, 2010
Apoptosis and cancer stem cells: Implications for apoptosis targeted therapyFrank A E Kruyt, Jan Jacob Schuringa
Blood|December 24, 2024
Menin inhibitors in the treatment of acute myeloid leukemiaGerwin Huls, Carolien M Woolthuis, Jan Jacob Schuringa
Plos One|November 1, 2014
ELMO1 is upregulated in AML CD34+ stem/progenitor cells, mediates chemotaxis and predicts poor prognosis in normal karyotype AMLMarta E Capala, Edo Vellenga, Jan Jacob Schuringa
STAR Protocols|October 8, 2021
CombiFlow: Flow cytometry-based identification and characterization of genetically and functionally distinct AML subclonesRoos Houtsma, Shanna M Hogeling, Jan Jacob Schuringa
Plos One|April 2, 2014
Convergence of hypoxia and TGFβ pathways on cell cycle regulation in human hematopoietic stem/progenitor cellsAlbertus T J Wierenga, Edo Vellenga, Jan Jacob Schuringa
Pageof 15